Dimensional Fund Advisors
PRAX icon

Dimensional Fund Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Dimensional Fund Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
31,574
+413
+1% +$131K ﹤0.01% 2278
2026
Q1 		$10M Buy
31,161
+7,618
+32% +$2.36M ﹤0.01% 2258
2025
Q4 		$6.94M Sell
23,543
-13,871
-37% -$2.58M ﹤0.01% 2415
2025
Q3 		$1.98M Buy
+37,414
New +$1.81M ﹤0.01% 2766
2025
Q1 		– Sell
-4,544
Closed -$350K – 3348
2024
Q4 		$350K Sell
4,544
-545
-11% -$39.4K ﹤0.01% 3086
2024
Q3 		$293K Sell
5,089
-1,799
-26% -$97.2K ﹤0.01% 3115
2024
Q2 		$284K Sell
6,888
-8,152
-54% -$385K ﹤0.01% 3113
2024
Q1 		$918K Buy
15,040
+1,330
+10% +$59.7K ﹤0.01% 2938
2023
Q4 		$305K Buy
13,710
+12,302
+874% +$222K ﹤0.01% 3131
2023
Q3 		$36.1K Hold
1,408
– – ﹤0.01% 3404
2023
Q2 		$24.3K Sell
1,408
-15,102
-91% -$231K ﹤0.01% 3445
2023
Q1 		$200K Buy
+16,510
New +$697K ﹤0.01% 3200
2022
Q3 		$93K Buy
+2,736
New +$136K ﹤0.01% 3349

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Dimensional Fund Advisors's PRAX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Praxis Precision Medicines (PRAX) stake by 1.3% in Q2 2026, buying an estimated $131K and bringing the position to 31,574 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Dimensional Fund Advisors first reported a position in PRAX in Q3 2022 and has held it in 13 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Dimensional Fund Advisors held 31,574 shares of Praxis Precision Medicines worth $10.6M as of Q2 2026.
  • Dimensional Fund Advisors bought 413 Praxis Precision Medicines shares in Q2 2026, an estimated $131K.
  • Praxis Precision Medicines made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2278 holding.
  • Dimensional Fund Advisors first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 13 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.